Breaking News

Norwich Names Pharma Development VP

January 17, 2013

Arnold to lead product development and technical services

Kristin Arnold, Ph.D. has been appointed vice president of product development and technical services (PDTS) at Norwich Pharmaceuticals. Dr. Arnold will provide strategic leadership for the PDTS group that includes R&D, GMP pilot scale manufacturing, analytical development and validation, and testing services. She reports to chief executive officer, Doug Drysdale.
 
Prior to joining the company, Dr. Arnold held positions with URL Pharma as senior vice president of Product Development, Alpharma as senior director R&D, FMC Corp., Ecogen, and Monsanto.
 
"We are pleased to welcome Kristin Arnold to Norwich and look forward to her contributions to the PDTS group and the organization," said Mr. Drysdale. "Her expertise in product development from product conception through market launch will be an advantage for our customers and she will be a strong addition to our leadership team."

Related Compliance:

blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision